J&J Begins Human Trials Of Experimental Ebola Vaccine
Bloomberg News: J&J Injects First Volunteer in Race to Make Ebola Vaccine
“Johnson & Johnson (JNJ) started a trial of its experimental Ebola vaccine in the U.K. and said it will produce two million courses of the shot this year…” (Bennett, 1/6).
Reuters: J&J, Bavarian Nordic start clinical tests in Ebola vaccine race
“…The initiation of the Phase I study in Britain, which had been expected about now, marks further progress in the race to develop a vaccine against a disease that has killed more than 8,000 people in West Africa since last year…” (Hirschler, 1/6).
Wall Street Journal: J&J Begins Human Testing of Ebola-Virus Vaccine
“…J&J said some volunteers have already received their initial vaccine dose, and enrollment is expected to wrap up by the end of the month. The early-stage clinical trial is being led by the University of Oxford’s pediatrics department…” (Dulaney, 1/6).